The dysregulation of TFEB expression and activity has been implicated in the progression of various diseases, including Parkinson's disease, Alzheimer's disease, Huntington's disease, and RagCS75Y cardiomyopathy 36-39. This evidence concerns the gene TFEB and early-onset autosomal dominant Alzheimer disease.